Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D, Singhal S, Frankfurt O, Tallman MS, Rosen ST, Mehta J, Gordon LI. Evens AM, et al. Among authors: mehta j. Br J Haematol. 2008 Feb;140(4):385-93. doi: 10.1111/j.1365-2141.2007.06908.x. Epub 2007 Dec 19. Br J Haematol. 2008. PMID: 18162124 Free article. Clinical Trial.
Lenalidomide in myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Curr Treat Options Oncol. 2007 Apr;8(2):154-63. doi: 10.1007/s11864-007-0011-7. Curr Treat Options Oncol. 2007. PMID: 17713723 Review.
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Winter JN, Inwards DJ, Spies S, Wiseman G, Patton D, Erwin W, Rademaker AW, Weitner BB, Williams SF, Tallman MS, Micallef I, Mehta J, Singhal S, Evens AM, Zimmer M, Molina A, White CA, Gordon LI. Winter JN, et al. Among authors: mehta j. J Clin Oncol. 2009 Apr 1;27(10):1653-9. doi: 10.1200/JCO.2008.19.2245. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255322 Free PMC article. Clinical Trial.
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.
Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA, Jovanovic B, Chadburn A, Stiff P, Winter JN, Mehta J, Van Besien K, Gregory S, Gordon LI, Shammo JM, Smith SE, Smith SM. Evens AM, et al. Among authors: mehta j. J Clin Oncol. 2010 Feb 20;28(6):1038-46. doi: 10.1200/JCO.2009.25.4961. Epub 2010 Jan 19. J Clin Oncol. 2010. PMID: 20085936 Free PMC article.
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gentzler RD, Evens AM, Rademaker AW, Weitner BB, Mittal BB, Dillehay GL, Petrich AM, Altman JK, Frankfurt O, Variakojis D, Singhal S, Mehta J, Williams S, Kaminer L, Gordon LI, Winter JN. Gentzler RD, et al. Among authors: mehta j. Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15. Br J Haematol. 2014. PMID: 24628515 Free article.
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.
Paudel N, Schulze D, Gentzler RD, Evens AM, Helenowski I, Dillehay G, Frankfurt O, Mehta J, Donnelly ED, Gordon LI, Winter JN, Mittal BB. Paudel N, et al. Among authors: mehta j. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):436-446. doi: 10.1016/j.ijrobp.2019.02.007. Epub 2019 Feb 11. Int J Radiat Oncol Biol Phys. 2019. PMID: 30763660 Clinical Trial.
Treatment of relapsed and refractory multiple myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Curr Treat Options Oncol. 2003 Jun;4(3):229-37. doi: 10.1007/s11864-003-0024-9. Curr Treat Options Oncol. 2003. PMID: 12718800 Review.
Novel therapies in multiple myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Int J Hematol. 2003 Apr;77(3):226-31. doi: 10.1007/BF02983778. Int J Hematol. 2003. PMID: 12731664 Review.
2,508 results